With sales expected to decline this year due to the weak U.S. dollar, the group will know if May 23 Brussels opened an investigation into the takeover of Moulinex. Currency fluctuations and in particular the 22% decline in the dollar against the euro could cost 7% sales growth at SEB in 2003. Before his shareholders [...]
By requiring the approval of its drug Alvesco asthma in the United States, the Franco-German takes its commitment to request, by the end of 2003, recording four new products. The title Aventis pranced ahead of the CAC 40 index yesterday (+ 0.78%, to 51.90 euros), after the pharmaceutical company announced the filing of an application [...]
With 6% to 10% of school children by region, asthma is both chronic illness of the child the most common… and the leading cause of school absenteeism. The worrying figures, up 10% a year for 20 years. Small consolation, France is not an isolated case. In 2001 asthma affecting more than 100 million people worldwide. [...]